首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.

Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.

导出 OA

翻译打印收藏纠错

第一作者： Meredith M,Regan

第一单位： Dana-Farber Cancer Institute, Boston, MA.;Harvard Medical School, Boston, MA.

作者： Meredith M,Regan ^[1] ; Lillian,Werner ^[2] ; Sumati,Rao ^[3] ; Komal,Gupte-Singh ^[3] ; F Stephen,Hodi ^[1] ; John M,Kirkwood ^[4] ; Harriet M,Kluger ^[5] ; James,Larkin ^[6] ; Michael A,Postow ^[7] ; Corey,Ritchings ^[3] ; Mario,Sznol ^[8] ; Ahmad A,Tarhini ^[9] ; Jedd D,Wolchok ^[7] ; Michael B,Atkins ^[10] ; David F,McDermott ^[11]

作者单位： Dana-Farber Cancer Institute, Boston, MA.;Harvard Medical School, Boston, MA. ^[1] Dana-Farber Cancer Institute, Boston, MA. ^[2] Bristol-Myers Squibb, Princeton, NJ. ^[3] University of Pittsburgh Cancer Institute, Pittsburgh, PA. ^[4] Yale Cancer Center, New Haven, CT. ^[5] The Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[6] Memorial Sloan Kettering Cancer Center, New York, NY.;Weill Cornell Medical College, New York, NY. ^[7] Yale University School of Medicine, New Haven, CT. ^[8] Emory University and Winship Comprehensive Cancer Center, Atlanta, GA. ^[9] Georgetown Lombardi Comprehensive Cancer Center, Washington, DC. ^[10] Harvard Medical School, Boston, MA.;Beth Israel Deaconess Medical Center, Boston, MA. ^[11]

医学主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);双盲法(Double-Blind Method);随访研究(Follow-Up Studies);人类(Humans);黑色素瘤(Melanoma);预后(Prognosis);存活率(Survival Rate)

DOI 10.1200/JCO.19.00345

PMID 31498030

发布时间 2020-12-10

基金项目

P30 CA016672/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States P50 CA121974/CA/NCI NIH HHS/United States P30 CA006516/CA/NCI NIH HHS/United States UL1 TR001863/TR/NCATS NIH HHS/United States P50 CA101942/CA/NCI NIH HHS/United States R01 CA216846/CA/NCI NIH HHS/United States R01 CA158167/CA/NCI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交